In this study, we found that high expression of lncRNA HAGLROS was associated with lymph node metastasis, distant metastasis, TNM stage and ER expression in breast cancer patients, and was associated with shorter overall survival in breast cancer patients, which could be an independent risk factor for poor prognosis in breast cancer patients. This evidence concerns the gene HAGLROS and metastatic malignant neoplasm in the lymph nodes.